COViMS (COVID-19 Infections in MS & Related Diseases) is a joint effort of the National MS Society, Consortium of MS Centers and Multiple Sclerosis Society of Canada to capture information on outcomes of people with MS and other CNS demyelinating diseases (Neuromyelitis Optica, or MOG antibody disease) who have developed COVID-19. Do they face special risks associated with COVID-19? Do certain disease modifying treatments incur special risks? Together, the two organizations along with several independent experts have designed and launched this North American MS registry.
====================================================
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews